Stay updated on Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the medical or healthcare-related publication or documentation content.
    Difference
    0.3%
    Check dated 2024-06-06T14:19:45.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    16 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 2023-07-17 to 2024-05-23, indicating a recent change in the study details related to the Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPC (CONTACT-02), possibly affecting medical and healthcare-related publications and documentation.
    Difference
    1.0%
    Check dated 2024-05-24T02:44:58.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of certain medical or healthcare-related publications or documentation. This change may reflect new information or additional studies being included in the database.
    Difference
    0.3%
    Check dated 2024-05-22T20:30:58.000Z thumbnail image
  8. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:34:49.000Z thumbnail image

Stay in the know with updates to Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib + Atezolizumab vs 2nd NHT in mCRPC: Clinical Trial page.